Security key
85205L107
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $.0001 per share
- Total 13F shares
- 66,260,215
- Total 13F value
- $1,702,158,459
- Share change
- -204,837
- Put/Call ratio
- 1.9%
- SEC-reported price per share
- $25.74
- Number of holders
- 146
- Value change
- -$5,021,341
- Number of buys
- 79
- Number of sells
- 59
- Shares outstanding
- 75,607,738
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
146
Top holders
10
SWTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
SpringWorks Therapeutics, Inc. SEC filings
SpringWorks Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 85205L107
Recent filing periods:
Ownership snapshot
Top reported holders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
12%
ORBIMED ADVISORS LLC
6.9%
Bain Capital Life Sciences Invest...
6.4%
VANGUARD GROUP INC
5.7%
STATE STREET CORP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
12%
|
$240,080,941
9,360,090 shares
|
— | 31 Dec 2022 |
| ORBIMED ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
6.9%
from 13F
|
$232,561,438
5,599,842 shares
|
— | 12 Sep 2022 |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
13F
10%+ Owner · Company
|
6.4%
from 13F
|
$200,690,112
4,832,413 shares
|
— | 10 Aug 2021 |
| VANGUARD GROUP INC |
13F
Company
|
5.7%
|
$112,424,454
4,322,355 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
5%
|
$97,685,471
3,755,689 shares
|
— | 31 Dec 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
4.6%
|
$90,000,010
3,460,208 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
146
Shares
66,260,215
Rows available
146
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q1 2023 holders
146
Holder diff
144
| Investor | Q4 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend